Trademark applications and grants for Veloxis Pharmaceuticals A/s. Veloxis Pharmaceuticals A/s has 27 trademark applications. The latest application filed is for "MELTDOSE"
State Incorporated | DENMARK |
Entity Type | CORPORATION |
Address | Amerika Plads 37 c/o Plesner Advokatpartnerselskab Copenhagen Ø DENMARK 2100 |
Patent Application | Date |
---|---|
Tacrolimus For Improved Treatment Of Transplant Patients 20210046055 - 17/085379 GORDON; Robert D. ;   et al. | 2021-02-18 |
Tacrolimus For Improved Treatment Of Transplant Patients 20210046054 - 17/085291 GORDON; Robert D. ;   et al. | 2021-02-18 |
SOLID DISPERSIONS COMPRISING TACROLIMUS 20200289478 - 16/657368 Holm; Per | 2020-09-17 |
REGIMEN FOR SUPPRESSING ORGAN REJECTION 20200268721 - 16/678527 Polvino; William J | 2020-08-27 |
STABILIZED TACROLIMUS COMPOSITION 20190282504 - 16/188805 Skak; Nikolaj ;   et al. | 2019-09-19 |
NCAGE Code | R7766 | VELOXIS PHARMACEUTICALS A/S |
CAGE Code | R7766 | VELOXIS PHARMACEUTICALS A/S |
SEC | 0001544387 | Veloxis Pharmaceuticals A/S/ADR |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.